This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hanna, Z Articles by Jolicoeur, P Search for Related Content PubMed PubMed Citation Articles by Hanna, Z Articles by Jolicoeur, P

Specific expression of the human CD4 gene in mature CD4+ CD8- and immature CD4+ CD8+ T cells and in macrophages of transgenic mice.

Laboratory of Molecular Biology, Clinical Research Institute of Montreal, Quebec, Canada.

ABSTRACT

The CD4 protein plays a critical role in the development and function of the immune system. To gain more insight into the mechanism of expression of the human CD4 gene, we cloned 42.2 kbp of genomic sequences comprising the CD4 gene and its surrounding sequences. Studies with transgenic mice revealed that a 12.6-kbp fragment of the human CD4 gene (comprising 2.6 kbp of 5' sequences upstream of the transcription initiation site, the first two exons and introns, and part of exon 3) contains the sequences required to support the appropriate expression in murine mature CD4+ CD8- T cells and macrophages but not in immature double-positive CD4+ CD8+ T cells. Expression in CD4+ CD8+ T cells was found to require additional regulatory elements present in a T-cell enhancer fragment recently identified for the murine CD4 gene (S. Sawada and D. R. Littman, Mol. Cell. Biol. 11:5506-5515, 1991). These results suggest that expression of CD4 in mature and immature T-cell subsets may be controlled by distinct and independent regulatory elements. Alternatively, specific regulatory elements may control the expression of CD4 at different levels in mature and immature T-cell subsets. Our data also indicate that mouse macrophages contain the regulatory factors necessary to transcribe the human CD4 gene.

This article has been cited by other articles:

• Priceputu, E., Hanna, Z., Hu, C., Simard, M.-C., Vincent, P., Wildum, S., Schindler, M., Kirchhoff, F., Jolicoeur, P. (2007). Primary Human Immunodeficiency Virus Type 1 Nef Alleles Show Major Differences in Pathogenicity in Transgenic Mice. J. Virol. 81: 4677-4693 [Abstract] [Full Text]  
• Priceputu, E., Bouallaga, I., Zhang, Y., Li, X., Chrobak, P., Hanna, Z. S., Poudrier, J., Kay, D. G., Jolicoeur, P. (2006). Structurally Distinct Ligand-Binding or Ligand-Independent Notch1 Mutants Are Leukemogenic but Affect Thymocyte Development, Apoptosis, and Metastasis Differently. J. Immunol. 177: 2153-2166 [Abstract] [Full Text]  
• Huang, Z., Xie, H., Ioannidis, V., Held, W., Clevers, H., Sadim, M. S., Sun, Z. (2006). Transcriptional Regulation of CD4 Gene Expression by T Cell Factor-1/beta-Catenin Pathway.. J. Immunol. 176: 4880-4887 [Abstract] [Full Text]  
• Priceputu, E., Rodrigue, I., Chrobak, P., Poudrier, J., Mak, T. W., Hanna, Z., Hu, C., Kay, D. G., Jolicoeur, P. (2005). The Nef-Mediated AIDS-Like Disease of CD4C/Human Immunodeficiency Virus Transgenic Mice Is Associated with Increased Fas/FasL Expression on T Cells and T-Cell Death but Is Not Prevented in Fas-, FasL-, Tumor Necrosis Factor Receptor 1-, or Interleukin-1{beta}-Converting Enzyme-Deficient or Bcl2-Expressing Transgenic Mice. J. Virol. 79: 6377-6391 [Abstract] [Full Text]  
• de Repentigny, L., Lewandowski, D., Jolicoeur, P. (2004). Immunopathogenesis of Oropharyngeal Candidiasis in Human Immunodeficiency Virus Infection. Clin. Microbiol. Rev. 17: 729-759 [Abstract] [Full Text]  
• Kay, D. G., Yue, P., Hanna, Z., Jothy, S., Tremblay, E., Jolicoeur, P. (2002). Cardiac Disease in Transgenic Mice Expressing Human Immunodeficiency Virus-1 Nef in Cells of the Immune System. Am. J. Pathol. 161: 321-335 [Abstract] [Full Text]  
• Simard, M.-C., Chrobak, P., Kay, D. G., Hanna, Z., Jothy, S., Jolicoeur, P. (2002). Expression of Simian Immunodeficiency Virus nef in Immune Cells of Transgenic Mice Leads to a Severe AIDS-Like Disease. J. Virol. 76: 3981-3995 [Abstract] [Full Text]  
• Hanna, Z., Weng, X., Kay, D. G., Poudrier, J., Lowell, C., Jolicoeur, P. (2001). The Pathogenicity of Human Immunodeficiency Virus (HIV) Type 1 Nef in CD4C/HIV Transgenic Mice Is Abolished by Mutation of Its SH3-Binding Domain, and Disease Development Is Delayed in the Absence of Hck. J. Virol. 75: 9378-9392 [Abstract] [Full Text]  
• Hanna, Z., Rebai, N., Poudrier, J., Jolicoeur, P. (2001). Distinct regulatory elements are required for faithful expression of human CD4 in T cells, macrophages, and dendritic cells of transgenic mice. Blood 98: 2275-2278 [Abstract] [Full Text]  
• Sarafova, S., Siu, G. (2000). Precise arrangement of factor-binding sites is required for murine CD4 promoter function. Nucleic Acids Res 28: 2664-2671 [Abstract] [Full Text]  
• Guan, J., Guillot, P. V., Aird, W. C. (1999). Characterization of the Mouse von Willebrand Factor Promoter. Blood 94: 3405-3412 [Abstract] [Full Text]  
• Zhang, X.-L., Seong, R., Piracha, R., Larijani, M., Heeney, M., Parnes, J. R., Chamberlain, J. W. (1998). Distinct Stage-Specific cis-Active Transcriptional Mechanisms Control Expression of T Cell Coreceptor CD8{alpha} at Double- and Single-Positive Stages of Thymic Development. J. Immunol. 161: 2254-2266 [Abstract] [Full Text]  
• Hanna, Z., Kay, D. G., Cool, M., Jothy, S., Rebai, N., Jolicoeur, P. (1998). Transgenic Mice Expressing Human Immunodeficiency Virus Type 1 in Immune Cells Develop a Severe AIDS-Like Disease. J. Virol. 72: 121-132 [Abstract] [Full Text]  
• Aird, W. C., Edelberg, J. M., Weiler-Guettler, H., Simmons, W. W., Smith, T. W., Rosenberg, R. D. (1997). Vascular Bed-specific Expression of an Endothelial Cell Gene Is Programmed by the Tissue Microenvironment. J. Cell Biol. 138: 1117-1124 [Abstract] [Full Text]